BridgeMD
Compares treatment options for Hip Osteoarthritis
Official title PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty
ClinicalTrials.gov ID: NCT07180979
What this study is testing
What is Ropivacaine 0.5% Injectable Solution?
Ropivacaine 0.5% Injectable Solution is an investigational medicine, being studied as a potential treatment for hip osteoarthritis.
Also referred to as Spinal Anesthesia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to evaluate whether different types of regional anesthesia can improve pain control and functional recovery after total hip arthroplasty in adult patients undergoing elective hip replacement surgery. The main questions it aims to answer are: Does the PENG block reduce opioid use in the first 48 hours after surgery more effectively than the combined L-ESPB + S-ESPB technique?
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 to 100
You may be able to join if
- Age ≥ 65 years
- ASA physical status I-III
- Elective unilateral THA via posterior or lateral approach
- Informed consent provided
You likely can't join if
- Allergy to study drugs (ropivacaine, dexamethasone)
- Chronic opioid use (\>30 MME/day)
- Coagulopathy or infection at the injection site
- BMI \> 40 kg/m²
- Pre-existing motor weakness or neuropathy in the affected limb
- Cognitive impairment precluding informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Poznan, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Poznan, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.